Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:27 PM
Ignite Modification Date:
2025-12-25 @ 1:43 PM
NCT ID:
NCT01722292
Group ID:
EG002
Title:
Phase 1b: 400 mg LY2940680 + C + E
Description:
400 mg LY2940680 administered orally once daily (QD) for 6 cycles. 100 mg per square meter (mg/m\^2) etoposide (E) administered by intravenous (IV) infusion on days 1, 2, 3 of each cycle.
Area under the Curve \[AUC\] 5 (mg•min/mL) carboplatin (C) administered by IV infusion on day 1 each cycle.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
14
Other Number Affected:
14
Other Number At Risk:
14
Study:
NCT01722292
Results Section:
NCT01722292
Adverse Events Module:
NCT01722292